MPM
WX

Meritage Portfolio Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Meritage Portfolio Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-189,125
Closed -$7.33M – 229
2015
Q1 		$7.33M Buy
189,125
+61,900
+49% +$2.38M 0.74% 26
2014
Q4 		$4.28M Sell
127,225
-160
-0.1% -$5.65K 0.46% 118
2014
Q3 		$4.46M Buy
+127,385
New +$4.37M 0.51% 102

Other funds holding WX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Meritage Portfolio Management's WX Position: Q2 2015 in Review

Meritage Portfolio Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 189,125 shares — an estimated $7.33M sold.

Meritage Portfolio Management first reported a position in WX in Q3 2014 and held it in 3 quarters. The position peaked at $7.33M in Q1 2015. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

  • Meritage Portfolio Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
  • Meritage Portfolio Management sold 189,125 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $7.33M.
  • Meritage Portfolio Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2014 and held it in 3 quarters.
  • Meritage Portfolio Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $7.33M in Q1 2015.
  • 154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Meritage Portfolio Management's 13F filing for Q2 2015, filed 22 Jul 2015.